Chris Wolfe

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Chris Wolfe
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Chris Wolfe

Form 4 holding Chief Financial Officer

DA32 Life Science Tech Acquisition Corp.

Security class
Class B Common Stock, par value $0.0001 per share
Shares / value
125,000
Estimated value
$1,250,000
Report date
05 Aug 2021
Price
$10.00
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

SelectQuote, Inc.

Security class
No securities are beneficially owned.
Shares / value
0
Estimated value
Report date
28 Feb 2025
Price
Ownership
Direct

Insider Reports Filed by Chris Wolfe

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .